Andelyn Biosciences

Andelyn Biosciences

Biotechnology Research

Columbus, Ohio 8,130 followers

Accelerating the development and manufacturing of innovative therapies to bring more treatments to more patients.

About us

Andelyn Biosciences is a gene therapy CDMO dedicated to Turning Hope into Reality™. Our capabilities span viral vector process and analytical development, adherent and suspension based GMP drug substance manufacturing up to 2,000L, as well as GMP plasmid process development and GMP manufacturing. We are located in Columbus, OH, USA. With more than 20 years of pioneering experience in viral vector and vaccine manufacturing, Andelyn offers its clients direct access to globally recognized thought leaders with extensive expertise. We have produced GMP material for over 75 worldwide clinical trials in addition to over 450 cGMP clinical batches and more than 2,000 research-grade productions. Andelyn provides research and tox grade plasmids with an additional offering of GMP plasmid manufacturing, advanced quality systems, full regulatory support, semi-automated to automated fill stations, and supply chain vertical integration. Our 180,000 sq ft clinical and commercial manufacturing facility comprises 16 upstream production suites for customization of new and tech transferred programs. Andelyn offers clinical through commercial-scale capabilities that will help accelerate the development and manufacturing of innovative therapies to bring more treatments to more patients.

Industry
Biotechnology Research
Company size
201-500 employees
Headquarters
Columbus, Ohio
Type
Privately Held
Founded
2020
Specialties
Biotechnology, Pharmaceuticals, Gene Therapy, Biological Sciences, Research, and CDMO

Locations

Employees at Andelyn Biosciences

Updates

Similar pages

Browse jobs

Funding

Andelyn Biosciences 1 total round

Last Round

Grant

US$ 5.0M

Investors

JobsOhio
See more info on crunchbase